SCHEMBL26468795

SCHEMBL26468795

CC1(C)c2ccccc2-c2cc3oc4cccc(-c5ccc(-c6ccc7ccc8cccnc8c7n6)c6ccccc56)c4c3cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.32
TSHR P16473 2/20 0.32
RAB9A P51151 2/20 0.32
PDE4D Q08499 2/20 0.31
HTR2C P28335 2/20 0.31
HTR2A P28223 1/20 0.31
HTR2B P41595 1/20 0.31
CCR1 P32246 4/20 0.31
CCR8 P51685 4/20 0.31
CCR5 P51681 3/20 0.31
TDP1 Q9NUW8 2/20 0.31
GMNN O75496 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26469890 0.86 ALOX5 (0.32) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL26468802 0.84 PGR (0.34) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL26468858 0.83 KDM4E (0.34) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL26468794 0.82 PGR (0.36) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL26468812 0.81 AHR (0.31) KDM4EHPGDHSD17B10L3MBTL1TSHR
SCHEMBL26468803 0.81 CCR1 (0.36) KDM4EMAPTALDH1A1L3MBTL1TSHR
SCHEMBL26469950 0.81 CCR1 (0.38) KDM4EMAPTALDH1A1L3MBTL1TSHR
SCHEMBL26468786 0.81 CCR1 (0.36) KDM4EMAPTALDH1A1L3MBTL1TSHR
SCHEMBL26468776 0.79 BACE1 (0.37) KDM4EMAPTALDH1A1L3MBTL1TSHR
SCHEMBL26468813 0.78 CCR1 (0.33) KDM4EMAPTALDH1A1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-04 US disclosed
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME PPOX, PAH, CRY2 KDM4E 907/4885MAPT 1617/4885ALDH1A1 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.